pause, retrace, run..., page-51

I know nothing about charting, so don't jump all over me for this - but doesn't a share usually fall to 'fill the gap' when it has this kind of upwards rise? Of course the news today helped the fall, but chances are it would have drifted back down anyway.

My brother died last March from complications for treatment of MDS. He was 63. It was the chemotherapy that shut down his organs, and he didn't even make it to stem cell treatment. We read a lot about the success of stem cell treatments and for younger patients, the success rate is good. However what we don't get told is that once you are over 60, prepping for a stem cell transplant is often too difficult and as in the case of my brother, it is the pre-treatment and chemotherapy which can kill you. He went into it knowing that, but hoping he would be the exception. We need milder treatments for older MDS/leukemia sufferers especially since the majority of MDS diagnoses are above 60 years of age. We need better drugs to at least prolong their lives and spare them from harsh chemotherapy.

Just something to think about: I have my reasons beyond profit for believing in this stock and hoping it has good results.